Neurology Alert – January 1, 2016
January 1, 2016
View Issues
-
Clinical Features and Treatment Response in Patients with NMO Spectrum Disorders
In a retrospective analysis of 871 relapses in 185 patients with neuromyelitis optica or an neuromyelitis optica spectrum disorder, the authors reported that more than 80% of patients will have a partial or complete remission from their initial course of therapy.
-
Disability, Anxiety, and Depression with Medication-overuse Headache
A brief intervention that focuses on patient education can be effective in reducing headache frequency and medication dependency in patients with medication overuse headache.
-
Simvastatin and Vitamin D for Migraine Prevention
In a randomized, double-blind, placebo-controlled trial of 57 adults with episodic migraine, simvastatin plus vitamin D was effective in the prevention of headache in adults with episodic migraine.
-
Acetylcholine Receptor Antibody Testing in Ocular Myasthenia Gravis
More than two-thirds of patients with ocular myasthenia will have a positive antibody test, and a high level may predict progression to generalized disease.
-
Vision Problems After Ischemic Stroke: Effects on Quality of Life
Visual impairments are common in stroke survivors and should prompt a careful ophthalmologic evaluation, since many of the problems are ocular and not neurological.
-
Left Atrial Dysfunction Without Fibrillation Increases Stroke Risk
Lleft atrial abnormalities that do not necessarily result in atrial fibrillation, may also increase the risk of stroke and should be investigated and searched for in patients with ischemic stroke consistent with cardiogenic embolism.
-
Loss of Consciousness at Onset of Aneurysmal SAH: Poor Prognosis
Loss of consciousness at onset of Aneurysmal subarachnoid hemorrhage is an indicator of early brain injury and predicts poor functional outcome or death at 12 months.
-
Small Vessel Disease Often Accompanies Large Vessel Intracranial Atherosclerosis
The SAMMPRIS trial investigated the consequences of medical vs endovascular therapy for the treatment of symptomatic intracranial atherosclerosis, and points out the high prevalence of coexisting small vessel disease with large vessel atherosclerosis.